Literature DB >> 16466594

Psychosocial effects of age-related macular degeneration.

K Berman1, H Brodaty.   

Abstract

BACKGROUND: Age-related macular degeneration (AMD) affects approximately 10% of persons aged 65-74 years and 30% of those aged 75 and older and is the major cause of blindness in old age. AMD is progressive and irreversible. AIM: To review the psychosocial effects of AMD.
METHOD: OVID data bases (MEDLINE, psycINFO and CINAHL) from 1966 to 2004 were reviewed.
RESULTS: AMD is associated with functional impairment, high rates of depression, anxiety and emotional distress and increased mortality. Risk factors for depression are not well-defined, except for the degree of functional impairment and impending or actual loss of vision in the second eye. Behavioral and self-management programs may be effective in managing depression associated with AMD, but few studies have been performed, and none using drugs or multimodal therapy.
CONCLUSION: AMD will become even more prevalent as the population ages. Identification of risk factors for psychological consequences and of effective interventions remain to be recognized.

Entities:  

Mesh:

Year:  2006        PMID: 16466594     DOI: 10.1017/S1041610205002905

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  17 in total

Review 1.  How does the macula protect itself from oxidative stress?

Authors:  James T Handa
Journal:  Mol Aspects Med       Date:  2012-04-05

Review 2.  The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD.

Authors:  Sayantan Datta; Marisol Cano; Katayoon Ebrahimi; Lei Wang; James T Handa
Journal:  Prog Retin Eye Res       Date:  2017-03-20       Impact factor: 21.198

3.  The macular degeneration and aging study: Design and research protocol of a randomized trial for a psychosocial intervention with macular degeneration patients.

Authors:  Silvia Sörensen; Katherine White; Wingyun Mak; Katherine Zanibbi; Wan Tang; Amanda O'Hearn; Mark T Hegel
Journal:  Contemp Clin Trials       Date:  2015-03-24       Impact factor: 2.226

Review 4.  Lipids, oxidized lipids, oxidation-specific epitopes, and Age-related Macular Degeneration.

Authors:  James T Handa; Marisol Cano; Lei Wang; Sayantan Datta; Tongyun Liu
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-07-30       Impact factor: 4.698

5.  Cost effectiveness of pegaptanib for the treatment of age-related macular degeneration in the UK.

Authors:  Sorrel E Wolowacz; Neil Roskell; Steven Kelly; Fiona M Maciver; Chris S Brand
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

6.  Toxic effects of A2E in human ARPE-19 cells were prevented by resveratrol: a potential nutritional bioactive for age-related macular degeneration treatment.

Authors:  Agustina Alaimo; Mariana Carolina Di Santo; Ana Paula Domínguez Rubio; Gabriela Chaufan; Guadalupe García Liñares; Oscar Edgardo Pérez
Journal:  Arch Toxicol       Date:  2019-12-02       Impact factor: 5.153

7.  Depressive and Anxiety Symptoms in Older Adults With Auditory, Vision, and Dual Sensory Impairment.

Authors:  Adam Simning; Meghan L Fox; Steven L Barnett; Silvia Sorensen; Yeates Conwell
Journal:  J Aging Health       Date:  2018-06-13

Review 8.  Cellular models and therapies for age-related macular degeneration.

Authors:  David L Forest; Lincoln V Johnson; Dennis O Clegg
Journal:  Dis Model Mech       Date:  2015-05       Impact factor: 5.758

9.  The emotional and physical impact of wet age-related macular degeneration: findings from the wAMD Patient and Caregiver Survey.

Authors:  Monica Varano; Nicole Eter; Steve Winyard; Kim U Wittrup-Jensen; Rafael Navarro; Julie Heraghty
Journal:  Clin Ophthalmol       Date:  2016-02-03

10.  Mental health measures of anxiety and depression in patients with retinal detachment.

Authors:  Maneli Mozaffarieh; Stefan Sacu; Thomas Benesch; Andreas Wedrich
Journal:  Clin Pract Epidemiol Ment Health       Date:  2007-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.